Zimmer Holdings (ZMH -0.1%) says it's received FDA 510(k) clearance to market its Patient Specific Instruments Shoulder system to complement its Trabecular Metal Reverse Shoulder system for reverse shoulder arthroplasty procedures.
The system uses 3-D visualization software to assist surgeons in creating a customized surgical plan for each patient, and then provides patient-specific surgical instrument guides to facilitate placement of the implant corresponding to the personalized surgical plan.
It has been available to a limited number of surgeons in Europe since May, and now with the clearance, it will be available to shoulder surgeons across the U.S.
Zimmer Holdings (ZMH +1%) gains today after saying that it's begun distributing its APEX Spine System, a set of implants and instruments designed to correct a broad range of spinal deformities as well as complex and degenerative spinal diseases. Under the terms of a long-term agreement with SpineCraft, Zimmer Spine will exclusively market the APEX Spine System to healthcare organizations across the U.S., Canada, Australia and New Zealand.
Zimmer Holdings (ZMH) acquires German-based NORMED Medizin-Technik - a provider of technologies for the foot and ankle, and hand and wrist reconstruction and trauma markets - for an undisclosed price. (PR)
Zimmer Holdings (ZMH -1.9%) slips today as Credit Suisse cuts their estimates on the company's Q1 and its reiterated Neutral on the shares. The firm says that it's at the high-end of guidance range, and U.S. knee/hip market growth needs to be more carefully watched. The company lowers its 2013/2014/2015 EPS estimates to $5.74/$6.24/$6.83, from $5.76/$6.30/$6.92 respectively.
Zimmer Holdings (ZMH) says it's announced the launch of Gel-One Cross-linked Hyaluronate at the 2013 American Academy of Orthopaedic Surgeons Annual Meeting today. Gel-One Hyaluronate is an injectable gel approved for the treatment of osteoarthritis of the knee.
Zimmer Holdings, Inc. (ZMH) declares $0.20/share quarterly dividend, 11% increase from prior dividend of $0.18. Forward yield 1.06%. For shareholders of record Mar. 29. Payable Apr. 26. Ex-div date Mar. 27. (PR)